Nvidia CEO Jensen Huang stated that artificial intelligence will bring not only a technological revolution but also a seismic transformation at the societal and economic levels. In a recent interview, Huang stated that we are at a turning point in human history and made it clear that Nvidia will be at the center of this transformation.

Jensen Huang believes in the transformative power of artificial intelligence

Over the years, Nvidia has become a pioneer in graphics processing with its GPU technologies and has recently positioned itself at the heart of the global technology ecosystem with its AI chips. The company’s chips form the basis of numerous applications, from generative AI systems like ChatGPT to large-scale models from Google and Microsoft. In this process, Nvidia has become not just a hardware manufacturer but also a shaper of the AI era.

Huang stated that the AI revolution will inevitably transform the business world and its impacts will be felt in every sector. “Everyone’s job will be affected. Some jobs will be lost,” he said, warning that this transformation will be painful in some respects.

Huang highlighted the potential for artificial intelligence to increase productivity, stating that this could lead to increased social well-being. However, despite this optimistic outlook, recent data from the World Economic Forum indicates that 41 percent of employers expect to see a workforce reduction due to AI by 2030.

Huang also addressed the potential for negative outcomes from AI products like Elon Musk’s Grok chatbot, stating that systems can now monitor their own output through other AIs. He noted that such security mechanisms are developing, but offered no definitive guidelines on their effectiveness.

According to Huang, one of the most promising areas for AI is the healthcare sector. The company’s vision is to utilize AI in drug development, accelerate understanding of human biology, and develop new solutions for difficult-to-treat diseases. In this respect, Nvidia is becoming not only a technology company but also a strategic player in the biotechnology and healthcare fields.